Aug 23, 2020
ELISA for quantification of transforming growth factor beta (TGF-β) in human serum or plasma.
- Angel A Justiz-Vaillant1,
- Belkis Ferrer-Cosme2
- 1University of the West Indies St. Augustine;
- 2"Saturnino Lora Torres' Provincial Teaching Clinical Surgical Hospital. Cuba
- University of the West Indies
- angel.vaillant@sta.uwi.edu
Protocol Citation: Angel A Justiz-Vaillant, Belkis Ferrer-Cosme 2020. ELISA for quantification of transforming growth factor beta (TGF-β) in human serum or plasma.. protocols.io https://dx.doi.org/10.17504/protocols.io.bj67krhn
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: August 23, 2020
Last Modified: August 23, 2020
Protocol Integer ID: 40895
Abstract
Transforming growth factor beta (TGF-β) is a multifunctional cytokine belonging to the transforming growth factor superfamily. TGFB proteins are made by all white blood cell lineages.It is a multipotent growth factor affecting cell differentiation, tissue repair, cell proliferation, matrix production and apoptosis. [1]
Reference
1. Clark DA, Coker R. Transforming growth factor-beta (TGF-beta).Int J Biochem Cell Biol. 1998;30(3):293-298. doi:10.1016/s1357-2725(97)00128-3
An anti-humanTGF-β coating antibody is adsorbed onto the microwells by incubation overnight at 4°C with carbonate-bicarbonate buffer.
Add 50 µl of human serum or plasma. Human TGF-β present in the serum or plasma binds to antibodies adsorbed into the microwells.
The microplate is blocked with 3% non-fat milk-PBS buffer and later wash to remove unbound proteins.
Fifty (50) µl of biotin-conjugated anti-TGF-β antibody is added. The optimal dilution must be investigated.
The microplate is rewashed with PBS-Tween 20 buffer, pH 7.4.
One hundred µl of streptavidin-HRP conjugate is added and it binds to the biotin-conjugated anti-TGF-β antibody. The optimal dilution of this conjugate must be investigated.
The plate is washed following incubation to remove the unbound Streptavidin-HRP.
Add 100 µl of 3',3',5',5'- tetramethylbenzidine (TMB; Sigma-Aldrich) into each well.
Incubate the microwells in the dark for 20 min.
A colored product is formed in proportion to the quantity of TGF-β present in the sample or standard.
The reaction is terminated by addition of 100 µl 3M H2SO4 and the absorbance is measured at 450 nm.
A standard curve is made from 7 human TGF-β standard dilutions and the human TGF-β sample concentration is determined.
For better results place the microplate on a microplate shaker in every incubation.